Dose-dense biweekly docetaxel combined with 5-fluorouracil as first-line treatment in advanced gastric cancer: a phase II trial Jian XiaoYonghe ChenPing Lan Original Paper 22 January 2015 Article: 38
Intraperitoneal administration of cisplatin plus bevacizumab for the management of malignant ascites in ovarian epithelial cancer: results of a phase III clinical trial Hui ZhaoXiaosong LiNan Du Original Paper 22 January 2015 Article: 37
Sentinel lymph node biopsy in breast cancer: the role of micrometastasis David Pérez-CallejoFernando FrancoMariano Provencio Original Paper 21 January 2015 Article: 36
Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3 Jianjun DiaoXue YangYao Zhang Original Paper 21 January 2015 Article: 35
Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis Li SunJie-Tao MaCheng-Bo Han Review Article 21 January 2015 Article: 34
Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies Wenjie XiaYoutao XuFeng Jiang Original Paper 21 January 2015 Article: 33
Outcomes of peripheral blood stem cell transplantation patients from HLA-mismatched unrelated donor with antithymocyte globulin (ATG)-Thymoglobulin versus ATG-Fresenius: a single-center study Wenrong HuangXiaoli ZhaoLi Yu Original Paper 15 January 2015 Article: 32
A systematic review and meta-analysis of the association between OGG1 Ser326Cys polymorphism and cancers Ping-Ting ZhouBo LiChun-Fang Gao Original Paper 15 January 2015 Article: 31
RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma Ya-nan LiangYu LiuDandan Tong Original Paper 15 January 2015 Article: 30
Survivorship in untreated breast cancer patients Carlos M. GalmariniOlivier TredanFelipe C. Galmarini Review Article 15 January 2015 Article: 29
Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome Ruobing LengGang LiaoLiangdan Tang Original Paper 14 January 2015 Article: 28
Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment Long BaiDong-sheng ZhangRui-hua Xu Original Paper 13 January 2015 Article: 27
Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR–ABL1 fusion Sarah L. McCarronStephen E. LangabeerRuth Morrell Short Communication 13 January 2015 Article: 26
Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma Fanghua GongGuiqin HouMingzhi Zhang Original Paper 13 January 2015 Article: 25
Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression Yi-sheng HuangZhi XueHua Zhang Original Paper 13 January 2015 Article: 24
Treatment on advanced NSCLC: Platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials Jian-Guo ZhouXu TianHu Ma Original Paper 13 January 2015 Article: 23
Peperotetraphin inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and apoptosis Yunzhi LiNing HeChengwu Zhai Short Communication 13 January 2015 Article: 22
Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway Pei-Pei LiLi-Li FengXin Wang Original Paper 10 January 2015 Article: 21
N-cadherin participated in invasion and metastasis of human esophageal squamous cell carcinoma via taking part in the formation of vasculogenic mimicry Feng WangXiang-ke LiQing-xia Fan Original Paper 10 January 2015 Article: 20
Clinical efficacy of preoperative chemotherapy with or without ifosfamide in patients with osteosarcoma of the extremity: meta-analysis of randomized controlled trials Wenmei SuZhennan LaiJiayuan Wu Original Paper 10 January 2015 Article: 19
Patients with distal intestinal gastric cancer have superior outcome with addition of taxanes to combination chemotherapy, while proximal intestinal and diffuse gastric cancers do not: does biology and location predict chemotherapy benefit? Ali Murat SedefFatih KöseHüseyin Abalı Original Paper 09 January 2015 Article: 18
CCR7 pathway induces epithelial–mesenchymal transition through up-regulation of Snail signaling in gastric cancer Jianping ZhangYunzhe ZhouYonggang Yang Original Paper 09 January 2015 Article: 17
An Anticancer Drug Unit for the whole provincial oncologic network of Piacenza: improving safety and savings Patrizia MordentiStefano VecchiaLuigi Cavanna Original Paper 09 January 2015 Article: 16
Prognostic factors for survival with bevacizumab-based therapy in colorectal cancer patients: a systematic review and pooled analysis of 11,585 patients Fausto PetrelliAndrea CoinuSandro Barni Review Article 09 January 2015 Article: 15
Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway Cuixia YangLinyan HeFeng Gao Original Paper 09 January 2015 Article: 14
Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone Zhigang WeiXin YeXiaoying Han Original Paper 09 January 2015 Article: 13
Single-agent bevacizumab is an effective treatment in recurrent glioblastoma Ilhan HacibekirogluHilmi KodazIrfan Cicin Original Paper 09 January 2015 Article: 12
Third-line chemotherapy with carboplatin, gemcitabine and liposomised doxorubicin for malignant pleural mesothelioma Vinicius Araújo B. de LimaJens Benn Sørensen Original Paper 09 January 2015 Article: 11
SOX5 promotes epithelial–mesenchymal transition and cell invasion via regulation of Twist1 in hepatocellular carcinoma Dong WangSheng HanXiangcheng Li Original Paper 09 January 2015 Article: 10
Trial of LVDP regimen (l-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma Y. Q. WangY. YangM. Jiang Original Paper 09 January 2015 Article: 9
Human mammary microenvironment better regulates the biology of human breast cancer in humanized mouse model Ming-Jie ZhengJue WangShui Wang Original Paper 09 January 2015 Article: 8
Therapeutic efficacy evaluation of postoperative adjuvant radiotherapy in mid-thoracic esophageal carcinoma patients underwent Ivor Lewis esophagectomy with two-field lymphadenectomy Yang YuZhou WangXiang-Yan Liu Original Paper 09 January 2015 Article: 7
Retraction Note to: The hypoxia-inducible factor-1 regulates the microRNA185 expression through binding to hypoxia response elements sequence 2 Zhenguo SongHe RenJihui Hao Retraction Note 09 January 2015 Article: 6
Clinicopathological features of thirty patients with primary breast lymphoma and review of the literature Y. B. ShaoX. F. SunH. Liu Original Paper 09 January 2015 Article: 5
MLF1 interacting protein: a potential gene therapy target for human prostate cancer? Lei ZhangGuoqing JiChen Shao Original Paper 09 January 2015 Article: 4
Rapid response of brain metastases to alectinib in a patient with non-small-cell lung cancer resistant to crizotinib Hitomi AjimizuYoung Hak KimMichiaki Mishima Letter to the Editor 03 January 2015 Article: 3
Slug signaling is up-regulated by CCL21/CXCR7 to induce EMT in human chondrosarcoma Guosong LiYanjun YangZiqing Zhang Original Paper 03 January 2015 Article: 2
SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway Jin LiYiming LaiZhenghui Guo Original Paper 01 January 2015 Article: 1
